Ruihan Dong

Ruihan Dong

Auto-generated profile, based on publicly available information

Ruihan Dong

Peking University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2025 in eLife
Verified
Journal Article
Open access
RDRuihan Dong
Ruihan Dong
RLRongrong Liu
Rongrong Liu
ZLZiyu Liu
Ziyu Liu
YLYangang Liu
Yangang Liu
GZGaomei Zhao
Gaomei Zhao
CZCheng Zhu
Cheng Zhu
Antimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target biomembranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here, we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor. The generative module learns hidden ‘grammars’ of AMP features and produces candidates sequentially pass antimicrobial predictor and antiviral classifiers. We discovered 16 bifunctional AMPs and experimentally validated their abilities to inhibit a spectrum of pathogens in vitro and in animal models. Notably, P076 is a highly potent bactericide with the minimal inhibitory concentration of 0.21 μM against multidrug-resistant Acinetobacter baumannii, while P002 broadly inhibits five enveloped viruses. Our study provides feasible means to uncover the sequences that simultaneously encode antimicrobial and antiviral activities, thus bolstering the function spectra of AMPs to combat a wide range of drug-resistant infections.

3 March 2025 in eLife preprints
Verified
Preprint
Open access
RDRuihan Dong
Ruihan Dong
RLRongrong Liu
Rongrong Liu
ZLZiyu Liu
Ziyu Liu
YLYangang Liu
Yangang Liu
GZGaomei Zhao
Gaomei Zhao
CZCheng Zhu
Cheng Zhu
Antimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target bio-membranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor. The generative module learns hidden ‘grammars’ of AMP features and produces candidates sequentially pass antimicrobial predictor and antiviral classifiers. We discover 16 bifunctional AMPs and experimentally validated their abilities to inhibit a spectrum of pathogens in vitro and in animal models. Notably, P076 is a highly potent bactericide with the minimal inhibitory concentration of 0.21 μM against multidrug-resistant A. baumannii, while P002 broadly inhibits five enveloped viruses. Our study provides feasible means to uncover sequences that simultaneously encode antimicrobial and antiviral activities, thus bolstering the function spectra of AMPs to combat a wide range of drug-resistant infections.

15 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
RDRuihan Dong
Ruihan Dong
QCQiushi Cao
Qiushi Cao
CSChen Song
Chen Song
In the post-antibiotic era, antimicrobial peptides (AMPs) serve as ideal drug candidates for their lower likelihood of inducing resistance. Computational models offer an efficient way to design novel AMPs. However, current optimization and generation approaches are tailored for different application scenarios. To address this challenge, we propose a novel AMP design model named AMPainter. Based on deep reinforcement learning, AMPainter integrates both optimization and generation tasks in a unified framework. We apply AM-Painter to three types of peptides, including known AMPs, signal peptides (SPs), and random sequences. AMPainter outperforms ten related models in enhancing the activity of known AMPs, and evolves effective AMPs from membrane-active SPs with a success rate of 80%. Furthermore, several de novo designed AMPs from random sequences are validated along with their evolutionary paths. Therefore, AMPainter contributes to paint antimicrobial potency to diverse peptides, assisting in expanding the AMP sequence space and discovering novel antimicrobial agents.

24 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RDRuihan Dong
Ruihan Dong
RLRongrong Liu
Rongrong Liu
ZLZiyu Liu
Ziyu Liu
YLYangang Liu
Yangang Liu
GZGaomei Zhao
Gaomei Zhao
CZCheng Zhu
Cheng Zhu
Antimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target bio-membranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor. The generative module learns hidden ‘grammars’ of AMP features and produces candidates sequentially pass antimicrobial predictor and antiviral classifiers. We discover 16 bifunctional AMPs and experimentally validated their abilities to inhibit a spectrum of pathogens in vitro and in animal models. Notably, P076 is a highly potent bactericide with the minimal inhibitory concentration of 0.21 μM against multidrug-resistant A. baumannii , while P002 broadly inhibits five enveloped viruses. Our study provides feasible means to uncover sequences that simultaneously encode antimicrobial and antiviral activities, thus bolstering the function spectra of AMPs to combat a wide range of drug-resistant infections.

3 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RDRuihan Dong
Ruihan Dong
TATadsanee Awang
Tadsanee Awang
QCQiushi Cao
Qiushi Cao
KKKai Kang
Kai Kang
LWLei Wang
Lei Wang
CSChen Song
Chen Song
Motivation: The membrane-lytic mechanism of antimicrobial peptides (AMPs) is often overlooked during their in silico discovery process, largely due to the lack of a suitable metric for the membrane-binding propensity of peptides. Previously, we proposed a characteristic called membrane contact probability (MCP) and applied it to the identification of membrane proteins and membrane-lytic AMPs. However, previous MCP predictors were not trained on short peptides targeting bacterial membranes, which may result in unsatisfactory performance for peptide studies. Results: In this study, we present PepMCP, a peptide-tailored model for predicting MCP values of short peptides. We collected more than 500 membrane-lytic AMPs from the literature, conducted coarse-grained molecular dynamics (MD) simulations for these AMPs, and extracted their residue MCP labels from MD trajectories to train PepMCP. PepMCP employs the GraphSAGE framework to address this node regression task, encoding each peptide sequence as a graph with 4-hop edges. PepMCP achieved a Pearson correlation coefficient of 0. 883 and an RMSE of 0. 123 on the node-level test set. It can recognize membrane-lytic AMPs with the predicted MCP values for each sequence, thereby facilitating mechanism-driven AMP discovery. Additionally, we provide a database, MemAMPdb, which includes the membrane-lytic AMPs, as well as the PepMCP web server for easy access. Availability and Implementation: The code and data are available at https://github.com/ComputBiophys/PepMCP.

21 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJiaxuan Li
Jiaxuan Li
CYChenguang Yang
Chenguang Yang
RDRuihan Dong
Ruihan Dong
JJJuan Francisco Bada Juarez
Juan Francisco Bada Juarez
LWLei Wang
Lei Wang
CSChen Song
Chen Song
The rise of antibiotic resistance has generated an urgent demand for the discovery of new antimicrobial peptides (AMPs), prompting the development of various screening strategies. However, the specific function mechanisms of AMPs are often overlooked during the screening and optimization processes. In this study, we introduce a mechanism-driven screening approach that employs machine learning-based computational models to identify peptide sequences that target membranes and form pores. This approach explicitly considers critical factors such as structural features, membrane ainity, and the ability of peptides to oligomerize. Our method was applied to the metaproteomes of poison frogs, African clawed frogs, and human skin, followed by experimental validation. Seven peptides were successfully screened, each demonstrating antimicrobial activity with minimal hemolysis and cytotoxicity. These peptides exhibited membrane disruption capabilities in liposome leakage assays, with three showing broad-spectrum antimicrobial activity. Furthermore, single-molecule experiments indicated that these peptides can oligomerize on membranes, while electrophysiological measurements detected pore formation, confirming the effectiveness of our screening strategy. Therefore, our screening approach can effectively identify AMP sequences that act through membrane-targeting and poreforming mechanisms, offering a promising, mechanism-driven strategy for the discovery of new antimicrobial agents to combat antibiotic resistance.